Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (81-90 of 339) with videos related to

Pageof 34
Sort By:
Blood|July 13, 2013
The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemiaJoshua R Veatch, Vicky Sandhu, Pamela S Becker, et al.
Leukemia & Lymphoma|February 9, 2021
Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203Anna Moseley, Megan Othus, Guillermo Garcia-Manero, et al.
Leukemia Research|June 21, 2011
Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabineRandall W Knoebel, Amy McQuary, Pamela Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Responsibility for costs associated with clinical trialsPaul J Martin, Nancy Davenport-Ennis, Nicholas J Petrelli, et al.
Blood|July 30, 2005
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanismRoland B Walter, Jason L Pirga, Michelle R Cronk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006Kristine Doney, Ted A Gooley, H Joachim Deeg, et al.
The New England Journal of Medicine|April 12, 2013
Implementing a Death with Dignity program at a comprehensive cancer centerElizabeth Trice Loggers, Helene Starks, Moreen Shannon-Dudley, et al.
Blood|February 14, 2004
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicinRoland B Walter, Brian W Raden, Michelle R Cronk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasiaBart L Scott, Barry E Storer, Joanne E Greene, et al.
British Journal of Haematology|March 22, 2003
Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemiaEric D Hsi, Kenneth J Kopecky, Frederick R Appelbaum, et al.
Pageof 34

Showing results (81-90 of 339) with videos related to

Sort By:
Pageof 34
Blood|July 13, 2013
The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemiaJoshua R Veatch, Vicky Sandhu, Pamela S Becker, et al.
Leukemia & Lymphoma|February 9, 2021
Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203Anna Moseley, Megan Othus, Guillermo Garcia-Manero, et al.
Leukemia Research|June 21, 2011
Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabineRandall W Knoebel, Amy McQuary, Pamela Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Responsibility for costs associated with clinical trialsPaul J Martin, Nancy Davenport-Ennis, Nicholas J Petrelli, et al.
Blood|July 30, 2005
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanismRoland B Walter, Jason L Pirga, Michelle R Cronk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006Kristine Doney, Ted A Gooley, H Joachim Deeg, et al.
The New England Journal of Medicine|April 12, 2013
Implementing a Death with Dignity program at a comprehensive cancer centerElizabeth Trice Loggers, Helene Starks, Moreen Shannon-Dudley, et al.
Blood|February 14, 2004
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicinRoland B Walter, Brian W Raden, Michelle R Cronk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasiaBart L Scott, Barry E Storer, Joanne E Greene, et al.
British Journal of Haematology|March 22, 2003
Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemiaEric D Hsi, Kenneth J Kopecky, Frederick R Appelbaum, et al.
Pageof 34